Although many types of cancers are sensitive to TRAIL-induced apoptosis, substantial numbers of cancer cells are resistant to TRAIL, especially highly malignant tumors such as pancreatic cancer, melanoma, and neuroblastoma [119]. Here, TNFSF10 is linked to familial pancreatic carcinoma.